documentation in pharma industry - An Overview
These authorities demand that pharmaceutical companies retain arduous documentation to ensure that products meet up with security and efficacy criteria. Lousy documentation may lead to solution remembers, regulatory penalties, and important reputational harm.Documents should have unambiguous contents: the title, nature, and intent should be Obvious